Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of enzyme inhibitors and receptor modulators. Its fluorinated pyrrolidine structure enhances metabolic stability and bioavailability in drug candidates. Commonly employed in medicinal chemistry for optimizing pharmacokinetic properties, especially in treatments targeting central nervous system disorders and metabolic diseases. The hydroxyl and carboxylate functional groups allow for further chemical modifications, enabling the creation of diverse compound libraries for biological screening.